Literature DB >> 26866730

Exosomes promote bone marrow angiogenesis in hematologic neoplasia: the role of hypoxia.

Junko H Ohyashiki1, Tomohiro Umezu, Kazuma Ohyashiki.   

Abstract

PURPOSE OF REVIEW: To review the data on angiogenesis related to exosomes secreted by tumor cells in hematologic neoplasia and to elucidate the role of exosomes and exosomal miRNA in the bone marrow microenvironment, especially under hypoxic conditions. RECENT
FINDINGS: Cross-talk between bone marrow tumor cells and surrounding cells, including endothelial cells, is important for tumor growth in hematologic neoplasia. In addition to conventional signaling pathways, exosomes, which are small endosome-derived vesicles containing miRNAs, can help to modulate the microenvironment without directly contacting nontumorous cells. The human myeloid leukemia cell line K562 secretes exosomes containing a large amount of miR-92a that enhances angiogenesis under normoxic and hypoxic conditions. With chronic hypoxia, exosomes secreted by multiple myeloma cells also enhance angiogenesis by targeting factor-inhibiting hypoxia-inducible factor-1 via miR-135b.
SUMMARY: Intercellular communication between tumor cells and a heterogeneous population of bone marrow stromal cells is mediated by exosomes containing various functional proteins, mRNA, and miRNA. Hypoxia is a major regulator of exosomal content and affects angiogenesis in various types of hematologic neoplasia. Functional analysis of exosomes and exosome-mediated cell-cell interactions not only clarifies molecular pathogenesis but also suggests new treatment strategies for hematologic neoplasia through targeting exosomes.

Entities:  

Mesh:

Year:  2016        PMID: 26866730     DOI: 10.1097/MOH.0000000000000235

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  23 in total

1.  A function-blocking CD47 antibody modulates extracellular vesicle-mediated intercellular signaling between breast carcinoma cells and endothelial cells.

Authors:  Sukhbir Kaur; Abdel G Elkahloun; Satya P Singh; Anush Arakelyan; David D Roberts
Journal:  J Cell Commun Signal       Date:  2017-11-29       Impact factor: 5.782

Review 2.  Focus on exosomes: novel pathogenic components of leukemia.

Authors:  Chao Yang; Huan Yang; Jia Liu; Lidan Zhu; Shicang Yu; Xi Zhang; Lei Gao
Journal:  Am J Cancer Res       Date:  2019-08-01       Impact factor: 6.166

Review 3.  Exosome and mesenchymal stem cell cross-talk in the tumor microenvironment.

Authors:  Theresa L Whiteside
Journal:  Semin Immunol       Date:  2017-12-27       Impact factor: 11.130

Review 4.  The emerging roles of tumor-derived exosomes in hematological malignancies.

Authors:  M Boyiadzis; T L Whiteside
Journal:  Leukemia       Date:  2017-03-21       Impact factor: 11.528

Review 5.  Royal Society Scientific Meeting: Extracellular vesicles in the tumour microenvironment.

Authors:  Ryan Charles Pink; Areeg A Elmusrati; Daniel Lambert; David Raul Francisco Carter
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-01-05       Impact factor: 6.237

Review 6.  Exosomes and Their MicroRNA Cargo: New Players in Peripheral Nerve Regeneration.

Authors:  Liming Qing; Huanwen Chen; Juyu Tang; Xiaofeng Jia
Journal:  Neurorehabil Neural Repair       Date:  2018-09       Impact factor: 3.919

Review 7.  A G-Protein Coupled Receptor and Macular Degeneration.

Authors:  Anna G Figueroa; Brian S McKay
Journal:  Cells       Date:  2020-04-08       Impact factor: 6.600

8.  Counteracting the effect of leukemia exosomes by antiangiogenic gold nanoparticles.

Authors:  Catarina Roma-Rodrigues; Alexandra R Fernandes; Pedro V Baptista
Journal:  Int J Nanomedicine       Date:  2019-08-26

9.  Extracellular Nanovesicles Secreted by Human Osteosarcoma Cells Promote Angiogenesis.

Authors:  Francesca Perut; Laura Roncuzzi; Nicoletta Zini; Annamaria Massa; Nicola Baldini
Journal:  Cancers (Basel)       Date:  2019-06-05       Impact factor: 6.639

Review 10.  Exosomes: mediators of bone diseases, protection, and therapeutics potential.

Authors:  Jyotirmaya Behera; Neetu Tyagi
Journal:  Oncoscience       Date:  2018-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.